Roy Strowd to Central Nervous System Neoplasms
This is a "connection" page, showing publications Roy Strowd has written about Central Nervous System Neoplasms.
Connection Strength
1.871
-
Strowd RE, Grossman SA. The Role of Glucose Modulation and Dietary Supplementation in Patients With Central Nervous System Tumors. Curr Treat Options Oncol. 2015 Aug; 16(8):36.
Score: 0.502
-
Strowd RE, Abuali IA, Grossman SA. Objective cerebrospinal fluid response to intraventricular rituximab in indolent CNS lymphoma. CNS Oncol. 2015; 4(3):131-5.
Score: 0.493
-
Strowd RE, Swett K, Harmon M, Carter AF, Pop-Vicas A, Chan M, Tatter SB, Ellis T, Blevins M, High K, Lesser GJ. Influenza vaccine immunogenicity in patients with primary central nervous system malignancy. Neuro Oncol. 2014 Dec; 16(12):1639-44.
Score: 0.458
-
Strowd RE, Knovich MA, Lesser GJ. The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies. Curr Treat Options Oncol. 2012 Dec; 13(4):451-64.
Score: 0.417